Navigation Links
Biomarkers: Technological and Commercial Outlook 2013-2023
Date:9/2/2013

rdiovascular Biomarker Research4.4.2 The Current State of Cardiovascular Disease Biomarker Research4.4.3 Cardiovascular Disease Diagnostics4.4.4 The Future of Cardiovascular Biomarker Research4.4.5 Cardiovascular Disease Biomarker Submarket: Revenue Forecast, 2013-20234.5 CNS Diseases Biomarker Submarket, 20124.5.1 The Current State of CNS Disease Biomarker Research4.5.2 Biomarker-Based Diagnostics for CNS Diseases4.5.2.1 DiaGenic: Targeting Neurodegenerative Diseases4.5.3 Neuroimaging Biomarkers: Limitations in Sensitivity May Restrict Market4.5.4 CSF Biomarkers: Biochemical Composition of CSF Offers Potential4.5.5 Alzheimer's Disease: Beyond Amyloid Beta4.5.6 Multiple Sclerosis: Search for Disease Biomarker4.5.7 Parkinson's Disease: Effective Biomarker Yet to be Discovered4.5.7.1 Fluid-Based Biomarker Discovery4.5.8 CNS Diseases Biomarker Submarket: Revenue Forecast, 2013-20234.6 Growth in Key Biomarker Indications, 2013-2023

5. Leading National Biomarker Markets, 2013-2023

5.1 The World Biomarkers Market: Regional Breakdown, 2012

5.2 The World Biomarkers Market: Regional Forecast, 2013-2023

5.3 Strong Base for Biomarker Research in US

5.3.1 The US Biomarker Market: Revenue Forecast, 2013-2023

5.4 Top 5 EU Biomarker Markets, 2012

5.4.1 Top 5 EU Biomarker Markets: Revenue Forecasts, 2013-2023

5.4.2 French Government Funds $17m Cancer Biomarker Effort

5.4.2.1 France: Biomarker Market Revenue Forecast, 2013-2023

5.4.3 Focus on Biomarkers Prompts Opening of New Centre in Germany

5.4.3.1 Germany: Biomarker Market Revenue Forecast, 2013-2023

5.4.4 UK: Increased Funding for Biomarker Research

5.4.4.1 The UK Biomarker Market: Revenue Forecast, 2013-2023

5.4.5 Healthcare Cuts Restricting Drug Development in Spain

5.4.5.1 Spain: Biomarker Mar
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Biomarkers: Technological and Commercial Outlook 2012-2022
2. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
3. Lockheed Martin and Nanyang Technological University to collaborate on nanotechnology
4. SCD-iBIO Announces Second International Forum on Commercializing Global Green
5. Micropharma Limited announces new agreement to commercialize novel natural health products
6. Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization
7. John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
8. Leveraging an Academic-Industry Partnership for Commercial Success, New Life Science Webinar Hosted By Xtalks
9. United Airlines and AltAir Fuels to Bring Commercial-Scale, Cost-Competitive Biofuels to Aviation Industry
10. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
11. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... members will be attending Pharma Ed Resources upcoming educational seminar and training ... industry leading speakers, this timely conference will provide Updates & Case Studies on ...
(Date:9/1/2015)... , September 2, 2015 ... auf die Forschung und Entwicklung neuartiger Therapien ... chronisch-entzündliche Darmerkrankungen und Reizdarm konzentriert, erhält vom ... dass sein neues Medikament patentiert wird. Das ... Allergien bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... 1, 2015 Prostate cancer is ... American men. One in seven men will be ... cases are diagnosed annually. That said, not every ... powerful new technique, MRI Fusion Biopsy, to more ... treating only the affected areas and monitoring ...
Breaking Biology Technology:Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4
... CryoLife, Inc., (NYSE: CRY ) ... today announced,that it has received 510(k) clearance ... its CryoValve(R) SG pulmonary human heart valve ... proprietary,SynerGraft technology is designed to remove allogeneic ...
... CHENGDU, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., ... modernized traditional Chinese medicine (TCM) based in Chengdu,China, ... of the Board of,Directors, will host a conference ... financial results., The conference call will take ...
... Feb 7 Dilon Technologies, makers of,a gamma imaging ... G. Moussa to the position of President and Chief ... in the medical device industry,having held a number of ... -- a health care corporation he ran as,CEO for ...
Cached Biology Technology:CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... for a trial to investigate the safety of a ... Allergy and Infectious Diseases (NIAID), part of the National ... Rochester, NY, Baltimore and Los Angeles will enroll a ... part of the NIAID-sponsored Vaccine and Treatment Evaluation Units ...
... remains a challenging problem. Building classifiers based on ... the selection of non-redundant but relevant genes is ... enough to allow diagnosis even in regular clinical ... regulatory pathways. Here an entropy-based method is proposed ...
... rate of HIV infection, warn two senior doctors in an ... people worldwide, including over 2 million children, are now infected ... 2003. , The underlying reason for this continuing increase is ... write the authors. , For instance, the search for a ...
Cached Biology News:NIAID Initiates Trial of Experimental Avian Flu Vaccine 2
... loci identification through targeting resequencing. ... intensive assay validation/optimization, high throughput PCR ... customer-supplied samples and sequence alignment and ... rapid and highly accurate identification of ...
... Luciferase-based ENGENISTM (Entire Gene/cDNA or Isolated Sequence) ... a quantitative approach for evaluation of a ... as an efficient target for RNA interference ... are not perfect, leaving the probability of ...
... Stabilizer is a is a bovine protein-free ... product is an aqueous solution that contains ... buffered saline), pH 6.6 - 7.2. ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
Biology Products: